GYRE THERAPEUTICS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
GYRE THERAPEUTICS, INC. has filed 1,598 SEC EDGAR filings since 16 Dec 2002

SEC filing history

Showing 901-925 of 1,000 matching filings.

Per page
25
Current page
37
CORRESP

CORRESP filing

Filing date
30 Jun 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
23 Jun 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-82442

TARGACEPT, INC.

Filing date
18 May 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-82442

AMENDMENT NO. 3 TO THE SCHEDULE 13D

Filing date
15 May 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

FORM 8-K

Filing date
14 May 2015
Reporting date
13 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-51173

FORM 8-K

Filing date
14 May 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

8-K

Filing date
12 May 2015
Reporting date
06 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-51173

8-K

Filing date
12 May 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

FORM 8-K

Filing date
16 Apr 2015
Reporting date
16 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

8-K

Filing date
06 Apr 2015
Reporting date
01 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-51173

8-K

Filing date
06 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-51173

CT ORDER filing

Filing date
31 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-82442

AMENDMENT NO. 2 TO SCHEDULE 13D

Filing date
18 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

FORM 8-K

Filing date
17 Mar 2015
Reporting date
11 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-82442

TARGACEPT, INC.

Filing date
17 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

FORM 8-K

Filing date
06 Mar 2015
Reporting date
06 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-51173

FORM 8-K

Filing date
06 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

FORM 8-K

Filing date
06 Mar 2015
Reporting date
06 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-51173

FORM 8-K

Filing date
06 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-82442

SC 13G/A filing

Filing date
17 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-82442

AMENDMENT NO. 1 TO SCHEDULE 13D

Filing date
10 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .